European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint virtual meeting

• Date:
  Tuesday, 1 June 2021, All day
• Location:
  Online
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

During the first day of the ‘Patients and Consumers’ (PCWP) and ‘Healthcare Professionals’ (HCPWP) Working Parties joint meeting, the European Commission (EC) and the Agency present on the future extension of EMA’s mandate. The meeting also focuses on communication and stakeholder engagement and on COVID-19 vaccines, therapeutics and safety surveillance.

On the second day, the PCWP/HCPWP discussion focuses on stakeholders’ involvement in Scientific Advisory Groups (SAGs). EMA also provides an update on the regulatory science research agenda and on Big Data. The final part of the meeting is dedicated to an update on the Electronic product information (ePI).

Documents

Meeting summary - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint virtual meeting on 1-2 June 2021

Adopted Reference Number: EMA/314725/2021

Agenda - European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint virtual meeting - June 2021

Adopted Reference Number: EMA/231316/2021

Presentation - EC’s legal proposal for EMA’s reinforced role in crisis preparedness and how it fits with other EC strategic initiatives (A.Rys, EC)

Presentation - How is EMA preparing for an extended mandate (N.Wathion, Z.Frias, EMA)

Presentation - COVID 19 vaccines and therapeutics - An update to the PCWP/HCPWP (M.Cavaleri, EMA)

Presentation - Monitoring the safety of COVID-19 vaccines using real-world data (C.Cohet, EMA)

Presentation - COVID-19 vaccines safety surveillance (G.Genov, EMA)

Presentation - Survey results of patient representatives attending Scientific Advisory Groups or Ad Hoc Expert Meetings (S.Groeneveld, EMA)

Presentation - Scientific Advisory Groups (SAGs) re-nominations (F.Pignatti, EMA)

Presentation - Recent progress on data and analytics and looking to the future (P.Arlett, EMA)

Presentation - EMA’s Regulatory Science Research Agenda (L.Liu, EMA)

Presentation - Electronic Product Information (ePI) for EU medicines (E.Scanlan, EMA)